Santa Rosa, CA, United States of America

Mark Geusen

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Irvine, CA (US) (2023)
  • Santa Rosa, CA (US) (2015 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Geusen

Introduction

Mark Geusen is a prominent inventor based in Santa Rosa, California, known for his significant contributions to the field of medical devices. With a total of 12 patents to his name, Geusen has made remarkable advancements in endovascular technology, particularly in the preservation of internal iliac structures.

Latest Patents

Among his latest patents is the "Internal Iliac Preservation Devices and Methods." This innovative system includes a catheter with both distal and proximal portions, a guidewire, and an integrated delivery system designed for effective internal iliac preservation. Another notable patent is the "Advanced Endovascular Graft and Delivery System," which focuses on endovascular prostheses and methods for deploying stent grafts within a patient's body. These inventions showcase Geusen's commitment to improving medical procedures and patient outcomes.

Career Highlights

Throughout his career, Mark Geusen has worked with several notable companies, including Trivascular, Inc. and Endologix, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical technology.

Collaborations

Geusen has collaborated with esteemed colleagues such as Michael V. Chobotov and Dale L. Ehnes. These partnerships have fostered a creative environment that has led to the development of groundbreaking medical devices.

Conclusion

Mark Geusen's work in the field of medical innovation has had a profound impact on endovascular procedures. His patents reflect a dedication to enhancing patient care through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…